ouabain has been researched along with proscillaridin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, WJ; Farr, CD; Fishwild, DM; Nair, AC; Tabet, MR; Wang, X; Welsh, WJ | 1 |
| Bohlin, L; Felth, J; Fryknäs, M; Gullbo, J; Lindskog, M; Rickardson, L; Rosén, J; Wickström, M | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Neugebauer, G | 1 |
| Graumann, G; Haustein, KO; Stephan, B | 1 |
| Kawaguchi, M; Nishida, H; Saito, H | 1 |
| Eim, C; Kirch, U; Li, SQ; Schneider, R; Schoner, W; Sich, B | 1 |
| Eim, C; Kirch, U; Lang, RE; Li, S; Schoner, W | 1 |
| Bielawska, A; Bielawski, K; Winnicka, K | 1 |
| Bielawska, A; Bielawski, K; Miltyk, W; Winnicka, K | 2 |
| Bielawska, A; Bielawski, K; Surazyński, A; Winnicka, K | 1 |
| Arribas, J; Barradas, M; Bernadó, C; Collado, M; Da Silva-Álvarez, S; Del Pino, P; Domínguez, E; Fernández-Marcos, PJ; Ferreirós, A; García-Caballero, T; Gómez, M; González, P; González-Barcia, M; Hernández-González, F; Ikonomopoulou, MP; Lalinde, M; Llanos, S; Loza, MI; Pedrosa, P; Picallos-Rabina, P; Pietrocola, F; Prats, N; Rodilla, V; Serrano, M; Soprano, E; Triana-Martínez, F; Vidal, A | 1 |
| Ferreira, RS; Qayed, WS; Silva, JRA | 1 |
15 other study(ies) available for ouabain and proscillaridin
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Binding Sites, Antibody; Binding, Competitive; Carbohydrate Sequence; Digoxin; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin Fab Fragments; Mice; Mice, Transgenic; Models, Molecular; Molecular Sequence Data; Ouabain; Progesterone; Quantitative Structure-Activity Relationship; Radioligand Assay | 2002 |
Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardenolides; Colonic Neoplasms; Digitoxin; Digoxin; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Irinotecan; NF-kappa B; Proscillaridin; Strophanthins | 2009 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
[Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)].
Topics: Animals; Binding, Competitive; Blood Proteins; Bufanolides; Digoxin; Electrocardiography; Guinea Pigs; Injections, Intravenous; Ouabain; Penicillamine; Proscillaridin; Protein Binding | 1977 |
Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
Topics: Animals; Arrhythmias, Cardiac; Cardiac Glycosides; Cymarine; Digitoxin; Digoxin; Dimethylformamide; Female; Guinea Pigs; Heart Conduction System; Male; Myocardial Contraction; Ouabain; Potassium; Proscillaridin; Stimulation, Chemical | 1975 |
[Effect of proscillaridin on active cation transport across human red cell membrane (author's transl)].
Topics: Adenosine Triphosphate; Adult; Biological Transport, Active; Bufanolides; Cell Membrane; Erythrocytes; Humans; In Vitro Techniques; Ouabain; Potassium; Proscillaridin; Sodium | 1974 |
Proscillaridin A immunoreactivity: a new endogenous cardiac glycoside?
Topics: Animals; Cardiac Glycosides; Cattle; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Hypothalamus; Immunoglobulin G; Muscle, Skeletal; Organ Specificity; Ouabain; Proscillaridin; Rats | 1997 |
Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities.
Topics: Adrenal Glands; Animals; Cardiotonic Agents; Cattle; Chromatography, High Pressure Liquid; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Hypothalamus; Ouabain; Proscillaridin; Sodium-Potassium-Exchanging ATPase | 1998 |
Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Digoxin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Kinetics; Models, Molecular; Ouabain; Proscillaridin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2006 |
Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Calcium; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Digoxin; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Inhibitory Concentration 50; Ouabain; Proscillaridin; Time Factors | 2007 |
Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells.
Topics: Blotting, Western; Calcium; Carbohydrate Sequence; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Digoxin; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Immunoprecipitation; Indicators and Reagents; Microscopy, Fluorescence; Molecular Sequence Data; Ouabain; Proscillaridin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2008 |
Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts.
Topics: Apoptosis; Digoxin; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Humans; Mitogen-Activated Protein Kinase Kinases; Ouabain; Proscillaridin; Signal Transduction | 2010 |
Identification and characterization of Cardiac Glycosides as senolytic compounds.
Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Breast Neoplasms; Cardiac Glycosides; Cell Line, Tumor; Cell Membrane; Cellular Senescence; Chondrocytes; Digoxin; Female; Fibroblasts; Humans; Hydrogen-Ion Concentration; Mice; Osteoarthritis; Ouabain; Proscillaridin; Pulmonary Fibrosis; Xenograft Model Antitumor Assays | 2019 |
In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations.
Topics: Antiviral Agents; COVID-19; Cysteine Endopeptidases; Digitoxin; Digoxin; Drug Repositioning; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Niclosamide; Ouabain; Papain; Proscillaridin; RNA-Dependent RNA Polymerase; SARS-CoV-2 | 2022 |